Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Trinean Signs a Global Agreement with Bayer CropScience

Published: Wednesday, June 12, 2013
Last Updated: Wednesday, June 12, 2013
Bookmark and Share
Bayer will use Trinean’s technology for biomolecule QC using spectral content profiling.

Trinean it has entered into a long-term agreement with Bayer CropScience to supply DropSense96 and Xpose droplet readers along with its proprietary cDrop spectral analysis software to Bayer CropScience's global operations. Bayer CropScience will be using Trineans technology for High Throughput quantification and quality control of isolated biomolecules to assure robust outcome of genetic tests in its molecular breeding program.

“Trinean is delighted to be a global supplier to Bayer CropScience. Our microfluidic technology matches the expectations of Bayer CropScience in terms of automation, minimal sample consumption and accurate quantification of a broad range of plant extracts.” said Yvan Sergeant, VP commercial operations of Trinean. “We are committed to helping Bayer CropScience reach its high standards in the genetic research and high-quality seeds for field and vegetable crops.”

A real challenge exists for all plant genetic labs to accurately quantify nucleic acid extracts from plant tissue due to variations in genome size and the presence of co-purified buffer components or plant metabolites influencing both the quantification result as well as downstream genetic tests. Unlike traditional methods, the Trinean technology performs an in-depth sample content analysis by profiling the measured UV/VIS absorbance spectrum for both the biomolecule of interest and interfering chemicals. This approach allows specific concentration determination and genuine purity analysis within a simple ‘drop & read’ approach.


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More Than 3,800+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Trinean to be Awarded ISO 9001:2008 Certification
Certification awarded for Trinean’s Quality Management System.
Tuesday, February 03, 2015
Trinean to Appoint New Board Member
Company announced that it appointed Mr Chris van Ingen as independent board member.
Friday, May 02, 2014
Trinean to Enter into Global Supply Agreement with QIAGEN
Trinean to manufacture and supply the QIAxpert - a micro-volume spectrometer for DNA and RNA quantitation and quality analysis.
Tuesday, January 21, 2014
Trinean Secures 1 Million Euro Financing
Capricorn Health-tech Fund to join the investor base.
Wednesday, May 29, 2013
Trinean Appoints New CEO and Secures 2.7 Million Euro Financing
Appointment of Philippe Stas as Company’s new CEO.
Monday, April 30, 2012
Scientific News
NIH Study Finds Calorie Restriction Lowers Some Risk Factors for Age-Related Diseases
Two-year trial did not produce expected metabolic changes, but influenced other life span markers.
Immunotherapy Agent Benefits Patients with Drug-Resistant Multiple Myeloma in First Human Trial
Daratumumab proved generally safe in patients, even at the highest doses.
Low-level Arsenic Exposure Before Birth Associated with Early Puberty in Female Mice
Study examine whether low-dose arsenic exposure could have similar health outcomes in humans.
Inciting an Immune Attack On Cancer Cells
A new minimally invasive vaccine that combines cancer cells and immune-enhancing factors could be used clinically to launch a destructive attack on tumors.
‘Mutation-Tracking’ Blood Test for Breast Cancer
Scientists have developed a blood test for breast cancer able to identify which patients will suffer a relapse after treatment, months before tumours are visible on hospital scans.
Cellular Contamination Pathway for Heavy Elements Identified
Berkeley Lab scientists find that an iron-binding protein can transport actinides into cells.
Intensity of Desert Storms May Affect Ocean Phytoplankton
MIT study finds phytoplankton are extremely sensitive to changing levels of desert dust.
Common ‘Heart Attack’ Blood Test May Predict Future Hypertension
Small rises in troponin levels may have value as markers for subclinical heart damage and high blood pressure.
LaVision BioTec Reports on the Neuro Research on the Human Brain After Trauma
Company reports on the work of Dr Ali Ertürk from the Institute for Stroke and Dementia Research at LMU Munich.
NIH Study Shows No Benefit of Omega-3 Supplements for Cognitive Decline
Research was published in the Journal of the American Medical Association.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!